Inositol is an organic compound of high biological importance that is widely distributed in nature. It belongs to the sugar family and is mainly represented by […]
Gynecol Endocrinol. 2013 Apr;29(4):375-9. Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, Cela V. Abstract OBJECTIVE: To evaluate the effects the administration of myo-inositol (MYO) on hormonal parameters in a group […]
Minerva Ginecol. 2010 Dec;62(6):525-31. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F Abstract AIM:Polycystic ovary syndrome is the most common cause of […]
Fertil Steril. 2005 Dec;84(6):1755-7. Lucidi RS1, Thyer AC, Easton CA, Holden AE, Schenken RS, Brzyski RG. In women with polycystic ovary syndrome, chromium picolinate (200 microg/d) improves glucose tolerance compared with placebo but does not improve ovulatory frequency […]
J Hum Reprod Sci. 2010 May;3(2):85-90. Sherwal V1, Malik S, Bhatia V. Ever since ovarian hyperstimulation syndrome (OHSS) was recognized as a clinical entity, various treatment modalities have been […]
Med Hypotheses. 2015 Jul;85(1):45-8. Brownley KA(1), Boettiger CA(2), Young L(3), Cefalu WT(4). Dietary chromium supplementation for the treatment of diabetes remains controversial. The prevailing view that […]
Gynecol Endocrinol. 2011 Apr;27(4):256-62.Galazis N(1), Galazi M, Atiomo W. The pathogenesis of polycystic ovary syndrome (PCOS) has been linked to the development of insulin resistance and […]
Fertil Steril. 2006 Jul;86(1):243-6. Lydic ML1, McNurlan M, Bembo S, Mitchell L, Komaroff E, Gelato M. Trivalent chromium (1000 microg), as chromium picolinate, given without change in diet or activity level, caused […]
um Reprod Update. 2010 Sep-Oct;16(5):459-66. Youssef MA1, van Wely M, Hassan MA, Al-Inany HG, Mochtar M, Khattab S, van der Veen F. Recently, dopamine agonists were proposed as a prophylactic treatment for ovarian […]
